Produced by Radar Finance Text | Edited by Li Yihui | Deep Sea BGI’s real-name “reporting scandal” has made new progress.

Regarding the reported incident of being "beaten and disabled by thugs", BGI stated that the person who had a conflict with it was not a BGI employee, and the matter has been handled by the local public security organs in accordance with the law and regulations.

BGI's latest financial report shows that the company achieved operating income of 6.766 billion yuan last year, a year-on-year decrease of 19.42%; net profit attributable to the parent company was 1.461 billion yuan, a year-on-year decrease of 30.08%. This was due to the intensified competition in the COVID-19 business market and the global unit price of COVID-19 nucleic acid reagents and tests.

decline.

He was reported again for inaccurate testing. “Many people think that the inaccurate BGI testing I reported was only for COVID-19 testing, not just COVID-19 testing. BGI’s testing is inaccurate in everything. For example, if the scale of a ruler is wrong, everything it measures will be inaccurate.

There are problems." Wang Deming said in an article.

According to his description, he knew that BGI's tests were inaccurate and reported it with his real name because when cooperating with BGI, he discovered that the company's positive rate for pregnant women's tests was ten times higher than the standards of the National Health Commission and WHO.

For example, according to the article, according to the data released by BGI itself, "as of May 2018, they had tested 3.13 million cases and detected 19,000 'abnormal' cases, with a combined probability of 1/164." With the National Health and Family Planning Commission and the World

According to official data from the World Health Organization, the incidence of Down syndrome is less than 1/1,000, which is still more than six times higher.

Wang Deming pointed to BGI’s technical flaws as the reasons for inaccurate detection, including different sequencing processes, multiple processes, and error-prone aspects.

It was mentioned that BGI’s test kits were found to be defective by the State Food and Drug Administration, and multiple BGI testing engineers told BGI that quality control products had failed in known hospitals.

In addition to Wang Deming's report, in July 2018, an article on Huxiu.com titled "BGI Cancer" hit the screen. According to the description in the article, the reason why a mother in Changsha City, Hunan Province gave birth to an abnormal baby was because of three

Even though the color ultrasound and B-ultrasound showed obviously abnormal data, the doctor still used the possible results of the non-invasive DNA test and gave advice to the mother to give up the confirmation test, which ultimately led to the mother giving birth to a baby with physiological defects and refusing to give birth.

Claims.

The article stated that because of the "low-risk" judgment made by BGI's non-invasive DNA test, three doctors successively misjudged it, and the mother gave up or ignored four other prenatal tests (Tang screening, ultrasound) under the doctor's advice.

,puncture).

BGI's conclusion directly and indirectly sent the family into the abyss.

And this Hunan family is just a microcosm of many tragic families with "non-invasive missed tests".

Subsequently, BGI issued a clarification announcement, stating that "the company clearly informed the applicable scope and technical limitations of non-invasive genetic testing in the relevant non-invasive informed consent form. Since non-invasive genetic testing as a screening technology has the risk of false negatives, in order to ensure

For each test subject, BGI purchases testing medical insurance.” Radar Finance found that in public reports in the past two years, there have been several cases questioning the accuracy of BGI’s new crown testing products.

On August 25, 2020, according to Reuters, the Swedish Public Health Agency recently announced that the testing reagents exported to the country by China's BGI were inaccurate, leading to the emergence of approximately 3,700 "false positive" cases.

The Public Health Department stated that two Swedish laboratories found through verification that BGI's testing reagents resulted in approximately 3,700 "false positive" results.

However, the article later stated that "most of the people with "false positive" results were people with only mild symptoms or no symptoms."

In response to this, BGI issued an announcement stating that the so-called "high positive detection rate" problem is mainly because asymptomatic infections usually have lower virus levels, and different countries and regions have different standards for the confirmation and management of asymptomatic infections.

difference.

In addition, late at night on April 22, 2021, according to a notice issued by the Hong Kong government, the BGI Laboratory reported 29 positive nucleic acid tests and 1 "indeterminate" case. Many patients were sent to the hospital and underwent nucleic acid tests.

and antibody tests were negative, indicating that they were not infected, which means BGI's test results may be "false positives."

In February 2021, the laboratory was warned by the Food and Health Bureau due to 16 "false positive" cases of new crown tests.

According to the analysis of the false positive investigation report submitted by BGI, possible errors include: human factors, reagent residue or contamination, and environmental pollution.

The police report mentioned that after an internal investigation by the laboratory, it was suspected that a laboratory assistant was suspected of shaking the new coronavirus test sample to affect the test results.

BGI stated that this person has repeatedly spread rumors and slandered BGI without any bottom line and violated BGI's reputation. His Weibo and WeChat accounts have also been permanently banned by the platform many times.

In this regard, BGI has defended its rights through judicial proceedings.